Stockscreener 앱 받기
0.2975
5.38%
0.0129
시간 외 거래:
.33
0.0325
+10.92%
전일 마감가:
$0.2846
열려 있는:
$0.2819
하루 거래량:
2.86M
Relative Volume:
0.72
시가총액:
$3.18M
수익:
-
순이익/손실:
$-22.70M
주가수익비율:
-0.0679
EPS:
-4.38
순현금흐름:
$-26.07M
1주 성능:
+3.63%
1개월 성능:
-34.82%
6개월 성능:
-99.07%
1년 성능:
-99.59%
1일 변동 폭
$0.272
$0.34
1주일 범위
$0.2704
$0.45
52주 변동 폭
$0.25
$77.50
Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile
명칭
Hepion Pharmaceuticals Inc
전화
732-902-4000
주소
399 THORNALL STREET, EDISON
HEPA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HEPA
Hepion Pharmaceuticals Inc
|
0.2975 | 3.18M | 0 | -22.70M | -26.07M | -4.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.50 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-07-20 | 재개 | ROTH Capital | Buy |
Hepion Pharmaceuticals Inc 주식(HEPA)의 최신 뉴스
Stocks of Hepion Pharmaceuticals Inc (HEPA) are poised to climb above their peers - Sete News
Financial Analysis: Hepion Pharmaceuticals (NASDAQ:HEPA) versus Salarius Pharmaceuticals (NASDAQ:SLRX) - Defense World
HEPA’s 52-Week Rollercoaster: From $0.25 to $79.50 – What’s Next for Investors? - investchronicle.com
Examining HEPA’s book value per share for the latest quarter - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
Holdings of Hepion Pharmaceuticals Inc (HEPA) are aligned with the stars - Sete News
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 2% – What’s Next? - Defense World
Hepion Pharmaceuticals (HEPA) Ends Merger with Pharma Two B - GuruFocus
Hepion Pharmaceuticals (HEPA) Announces $9M Public Offering Laun - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference - ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pharma Two B Presents Positive P2B001 Data for Parkinson's Disea - GuruFocus
Hepion Pharmaceuticals (HEPA) to Implement 1-for-50 Reverse Stoc - GuruFocus
Hepion Pharmaceuticals, Inc. SEC 10-K Report - TradingView
HEPA stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com Canada
Is Hepion Pharmaceuticals Inc’s -99.59% Fall This Year Is A Better Investing Opportunity? - Marketing Sentinel
Before You Invest, Make Sure You Check This Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Analysis - Stocksregister
Hepion Pharmaceuticals Delays Annual Report Filing - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Is Hepion Pharmaceuticals Inc (HEPA) worth investing in despite its undervalued state? - uspostnews.com
Hepion Pharmaceuticals announces 1-for-50 reverse stock split - MSN
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Fall -98.12% In Six Months, Here’s What We Should Expect Now - Marketing Sentinel
HEPA stock plunges to 52-week low, touches $0.67 By Investing.com - Investing.com UK
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 7.2% – Here’s Why - Defense World
Hepion Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals faces potential Nasdaq delisting - Investing.com
Hepion Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com India
Hepion Pharmaceuticals enacts reverse stock split - Investing.com
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split Effective March 17, 2025 - Nasdaq
Upcoming Stock Splits This Week (March 17 to March 21) – Stay Invested - The Globe and Mail
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split - ROI-NJ.com
Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split To Maintain Nasdaq Listing - Nasdaq
Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements - Investing.com Australia
Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals Announces Reverse Stock Split - citybiz
Hepion Plans Massive 1:50 Reverse Split to Save NASDAQ ListingWhat Shareholders Must Know - StockTitan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
An In-Depth Look At Hepion Pharmaceuticals Inc (HEPA) - Marketing Sentinel
HEPA stock plunges to 52-week low, touches $0.08 - Investing.com Australia
HEPA stock plunges to 52-week low, touches $0.08 By Investing.com - Investing.com South Africa
Hepion Pharmaceuticals releases unaudited balance sheet - Investing.com India
Hepion Pharmaceuticals Inc (HEPA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.52%
자본화:
|
볼륨(24시간):